Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Riding Out the Pandemic: A Q&A with Norman Gaylis, MD

Kimberly Retzlaff  |  November 30, 2020

Dr. Norman Gaylis

Dr. Norman Gaylis

Community physicians are doing their best to ride out the COVID-19 pandemic and keep their businesses viable while also keeping their staff and patients safe. The continuing need for enhanced safety precautions and lasting declines in patient volumes have taken a toll, both in terms of revenue losses and increasing workloads. The only option is to keep moving forward in hopes that things will get back to normal soon, says Norman Gaylis, MD, a community rheumatologist in Aventura, Fla.

Following up on his July interview related to the financial effects of the pandemic, Dr. Gaylis spoke to The Rheumatologist (TR) again about how his practice is faring as the pandemic drags on.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

TR: Over the summer, you were concerned about keeping your practice financially viable. What do things look like for you now?
Dr. Gaylis: Since then, we’ve definitely come back to a more normal patient flow. But it’s still probably off about 20–25% because patients are very apprehensive about coming into the office.

We’re still trying to protect all patients and staff by being proactive with body temperature measurements, social distancing and rapid testing to reduce the risk of COVID exposure and have seemingly managed to do so to this point. We presented an abstract at ACR Convergence 2020 to show our results.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Financially, I’m wondering if we’ll ever get any more help from the Paycheck Protection Program. This pandemic has taken a significant economic hold on businesses, as well as families, so having further support for the practice is critical.

But the reality is, we can’t make up what we lost. I’m projecting that our revenues are going to be down somewhere in the region of 30–35% by the end of the year.

TR: In July, you began implementing furlough days for staff. How did it go?
Dr. Gaylis: Dealing with the staffing was—quite honestly—very difficult. I basically asked everybody to take off one day a week and [accept] a 20% reduction in salary. But after one month, I realized it wasn’t going to work. Everybody in this practice is a link in the chain; so when we took a link out, it became less productive and more costly.

The staff is working now pretty much for the same salaries they were prior to the pandemic. The people who have taken the brunt of the financial burden are the physicians, the providers. My thinking was the highest salary people should take a reduction in salary, because we can probably deal with it, as much as it’s not very pleasant.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice Support Tagged with:COVID-19telemedicine

Related Articles

    Dr. Sou-Pan Wu Is the First Recipient of the Norman B. Gaylis Research Award

    May 29, 2019

    The Norman B. Gaylis, MD, Research Award for Rheumatologists in Community Practice is designed to encourage practicing clinicians to conduct their own research for the betterment of patients and rheumatology. The 2019 inaugural honoree is Sou-Pan Wu, MD, who will research gout in the Hmong population in Minnesota…

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Financial Impacts of COVID-19 on Practices: Q&A with Norman Gaylis, MD

    July 17, 2020

    Community rheumatology practices are confronting a significant financial fallout from stay-at-home orders and fears that keep patients at home, as well as reimbursement challenges.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences